| Name | Title | Contact Details |
|---|---|---|
Jeremy Abney |
Sr. Director, Procurement | Profile |
AMB Sports and Entertainment, based in Atlanta, Georgia, is a dynamic organization under the Blank Family of Businesses, led by entrepreneur Arthur Blank. The company manages a diverse portfolio that includes professional sports teams, venues, and retail operations. Key components of AMB Sports and Entertainment include the NFLs Atlanta Falcons, the MLSs Atlanta United FC, and the Atlanta Drive GC, which is set to debut in the Tomorrow Golf League in 2025. The company operates the Mercedes-Benz Stadium, a versatile venue for sports and major events, and The Home Depot Backyard, an outdoor space for community activities. Additionally, it runs the PGA TOUR Superstore, a nationwide golf retail chain. AMBSE Ventures focuses on strategic investments in sports technology and entertainment. The organization is committed to community engagement through various initiatives, including diversity programs and large-scale events. With a dedicated leadership team and a growing workforce, AMB Sports and Entertainment continues to enhance its impact in the sports and entertainment landscape.
Kavak is a global company with operations in Mexico, Argentina, Brazil, Chile, Turkey, Saudi Arabia, Oman and United Arab Emirates. We are the number one e-commerce company in the purchase and sale of pre-owned vehicles and the most highly valued private startup in Latin America. Kavak is also the first Unicorn Company in the history of Mexico, with a current valuation of US$8.7 billion. We have thousands of kavak@s from more than 40 different nationalities and growing. As part of this accelerated growth, we want to make sure we surround ourselves with the best talent to help us continue to build the technology, processes and products that will allow us to transform the automotive market around the world. Our team is the number one priority. We like to imagine the impossible and work together to achieve it. We are disruptive, proactive, loyal and ambitious. Interested in joining? Apply now.
Introducing life insurance made for living. Build your financial confidence with the power of protection and tax-deferred growth. Thats living Happy Everly After. Agency services provided by Everly, LLC, AR Insurance License # 3001180536 and CA Insurance License # 6004464. For a full list of states Everly is licensed to conduct business in, please refer to everlylife.com. Everly does not transact business in the state of New York. Something big is happening here. Do you fiercely challenge the way things have always been done? Are you ready to help change the way the world sees, buys and LIVES life insurance? Are you a tech-driven, data loving, customer obsessed, creative powerhouse looking for a new challenge? Sounds like we might be a good fit. Check out the open positions in our job board!
Herspiegel is a consulting firm based in Pennsylvania, founded in 2007, that specializes in pharmaceutical and biotech commercialization services. With over fifteen years of experience, the company has supported more than 150 product launches across various therapeutic areas, including primary care, oncology, and rare diseases. Their mission is to create a model for successful pharmaceutical product launches. The firm offers a wide range of services tailored to the life sciences industry, including market access, medical affairs, marketing strategy, and operational execution. Herspiegels team consists of over 350 experts, including MDs, PhDs, MBAs, and pharmacists, who provide deep knowledge to help clients navigate complex challenges and maximize brand potential. They serve a diverse clientele, from startups to large global pharmaceutical companies, focusing on strategic insights and operational excellence to enhance commercial success and patient outcomes. Herspiegel has also expanded its capabilities through strategic acquisitions, such as Decisive Consulting, which enhances their market access and value strategy services. This positions Herspiegel to deliver innovative solutions in a dynamic pharmaceutical landscape.